[Transcatheter Aortic Valve Implantation in Multivalvular Heart Disease]. / Transkatheter-Aortenklappenimplantation (TAVI) bei multivalvulären Herzerkrankungen.
Praxis (Bern 1994)
; 112(2): 65-73, 2023 Feb.
Article
em De
| MEDLINE
| ID: mdl-36722107
Transcatheter Aortic Valve Implantation in Multivalvular Heart Disease Abstract. The prevalence of multivaluvular heart disease is high in patients undergoing transcatheter aortic valve implantation (TAVI). The most common combination is aortic valve stenosis (AS) and mitral regurgitation, followed by the combination of AS with a tricuspid regurgitation or mitral stenosis. Grading of multivalvular disease is challenging and can quickly lead to underestimation of the disease stage. Therefore, a profound knowledge of pathophysiologic interactions is essential, and the patient should always undergo multimodal evaluation. After a successful TAVI intervention, secondary heart valve defects may improve, deteriorate, or remain unchanged. Due to the still sparse scientific data in this field, the role of the heart team remains central to provide the patient with an individually adapted therapy plan.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Estenose da Valva Aórtica
/
Substituição da Valva Aórtica Transcateter
/
Insuficiência da Valva Mitral
Tipo de estudo:
Risk_factors_studies
Limite:
Humans
Idioma:
De
Revista:
Praxis (Bern 1994)
Assunto da revista:
MEDICINA
Ano de publicação:
2023
Tipo de documento:
Article
País de publicação:
Suíça